Health ❯ Neurodegenerative Diseases ❯ Dementia
Clinical Trials Hormonal Influence Modifiable Risks Midlife Indicators
A Lancet Psychiatry analysis of 5,811 Whitehall II participants highlights symptom-level signals that could guide early prevention, with calls for replication.